HOUSTON (Oct. 1, 2023) — Innovation Map recently highlighted the cutting-edge research of Emerson Perin, MD, PhD, who is utilizing...
The Texas Heart Institute and the European Society for Cardiology Working Group for Cardiovascular Regenerative and Reparative Medicine hosted their 3rd Symposium...
Investigators at The Texas Heart Institute (THI) have gained new insights into patient-related factors that may affect clinical outcomes after...
THI Medical Director Emerson C. Perin, MD, PhD, outlines Phase 3 Clinical Trial Results Demonstrate Promising Stem Cell Treatment Options...
In response to the evolving Covid-19 pandemic, the Texas Heart Institute (THI) is dedicating its education series, Innovative Technologies & Techniques, to...
In response to the evolving pandemic, the Texas Heart Institute (THI) is dedicating its education series, Innovative Technologies & Techniques, to providing...
Dr. Perin, Texas Heart Institute’s Medical Director, is a world-renowned cardiologist known for his leadership in the development of stem...
Stem cell-based interventions offer great hope to patients with debilitating illnesses and injuries. However, only a limited number of therapies...
Stem cell-based inventions offer great hope to patients with debilitating illnesses and injuries. However, only a limited number of treatments...
The THI International Symposium on Cardiovascular Regenerative Medicine welcomes physicians, surgeons and scientists from around the world who are leading cardiovascular regenerative...
Dear Flavio, We are moving forward with stem cell research at THI. We are currently treating patients with heart failure...
There will be in the near future, but if your LVEF has improved from 20% to 40% recently, you may...
Visit U.S. News & World Report
